Table 2.
Studies investigating the risk of diabetes mellitus in patients with PsA
| First author, year of publication | County | Sample size | Measure of association | Risk of diabetes mellitus in patients with PsA | Type of study |
|---|---|---|---|---|---|
| Eder, 2017 | Canada | 1305 | Age-standardized prevalence ratio | 1.43 (95% CI 1.2–1.7) | Cross sectional |
| Coto-Segura, 2013 | UK, US, China | 16,914 | OR | 2.18 (95% CI 1.36–3.50) | Meta-analysis |
| Castañeda, 2015 | Spain | 2234 | OR | 5.08 (95% CI 2.22–11.64) | Prospective study |
| Queiro, 2018 | Spain | 340 | OR | 2.80 (95% CI 1.7–4.3) | Cross-sectional |
| Kibari, 2019 | Israel | 34,771 | OR | 1.48 (95% CI 1.36–1.61) | Cross-sectional |
| Dreiher, 2013 | Israel | 1647 | OR | 1.60 (95% CI 1.02–2.52) in females | Cross-sectional |
| 1647 | OR | 0.71 (95% CI 0.42–1.22) in males | Cross-sectional | ||
| Tam, 2008 | Hong Kong | 185 | OR | 9.27 (95% CI 2.09–41.09) | Cross-sectional |
| Kaine, 2019 | US | 49,935 | HR | 1.41 (95% CI 1.27–1.56) | Cross-sectional |
| Charlton, 2018 | UK | 6783 | RR | 1.40 (95% CI 1.15–1.70) | Prospective study |